fluorodeoxyglucose f18 has been researched along with Glioma in 266 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (7.14) | 18.7374 |
1990's | 46 (17.29) | 18.2507 |
2000's | 69 (25.94) | 29.6817 |
2010's | 113 (42.48) | 24.3611 |
2020's | 19 (7.14) | 2.80 |
Authors | Studies |
---|---|
Doi, H; Hume, WE; Ishii, A; Mawatari, A; Nakatani, Y; Nozaki, S; Tanaka, M; Tsuyuguchi, N; Wada, Y; Watanabe, Y | 1 |
Barberi-Heyob, M; Beaumont, M; Clément, A; Collet, C; Doyen, M; Filosa, R; Martin, B; Maskali, F; Ovdiichuk, O; Pouget, C; Roeder, E; Verger, A; Zaragori, T | 1 |
Albert, NL; Borgwardt, L; Fahey, FH; Galldiks, N; Hargrave, D; Jehanno, N; Kurch, L; Law, I; Lim, R; Lopci, E; Marner, L; Morana, G; Piccardo, A; Seghers, VJ; Shulkin, BL; Traub-Weidinger, T; Warren, KE; Young Poussaint, T; Zucchetta, P | 1 |
Alavi, A; Ayubcha, C; Borja, AJ; Nagaraj, C; Raynor, WY; Revheim, ME; Saini, J; Werner, TJ | 1 |
Alavi, A; Hustinx, R; Kumar, R; Withofs, N | 1 |
Cao, X; Chen, J; Chen, S; Gao, J; Huang, D; Kan, Y; Li, Y; Liu, Z; Pan, H; Tang, Y; Wang, J; Wang, L; Wen, Z; Xu, X; Zhang, L | 1 |
Arakawa, Y; Fushimi, Y; Hinoda, T; Ikeda, S; Makino, Y; Mineharu, Y; Miyamoto, S; Nakajima, S; Nakamoto, Y; Okuchi, S; Sakata, A; Yoshida, K | 1 |
Ecsedi, B; Grahovac, M; Hacker, M; Haug, A; Kluge, K; Krajnc, D; Li, X; Papp, L; Rasul, S; Spielvogel, CP; Traub-Weidinger, T; Zhao, M | 1 |
Chinot, O; Graillon, T; Guedj, E; Horowitz, T; Salgues, B; Tabouret, E; Verger, A | 1 |
Diaz-Arias, LA; Habis, R; Probasco, JC; Roman, S; Sadaghiani, MS; Solnes, LB; Venkatesan, A | 1 |
Bagul, SD; Basu, S; Chandak, AR; Shelly, D; Singh, BK; Singh, RK; Soni, BK; Sudhan, MD; Verma, P | 1 |
Cheng, X; Dai, C; Jiang, C; Kong, Z; Li, L; Lin, Y; Liu, D; Liu, Z; Ma, W; Qin, X; Tian, J; Wang, Y | 1 |
Bund, C; Cicek, AE; Lhermitte, B; Namer, IJ; Proust, F; Ruhland, E | 1 |
Ai, L; Chen, Q; Chen, Z; Fan, D; Li, X; Qiao, Z; Wang, K; Wang, X; Wu, T; Zhao, X | 1 |
Fan, B; Hu, M; Ma, L; Mu, D; Yang, G; Yu, J; Zhao, S; Zheng, J; Zhu, Y | 1 |
Bertaux, M; Kas, A; Pyatigorskaya, N; Sgard, B; Yahia-Cherif, L | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Gao, YF; Guan, Y; Hua, W; Kong, Y; Li, SH; Liu, FM; Wen, W; Ye, D; Zhang, J; Zuo, C | 1 |
Bakhshi, SK; Hasnain, N; Mustafa, RM; Shamim, MS | 1 |
Bartha, R; Fox, MS; Hoffman, L; Lee, TY; Lim, H; Qi, Q; Scholl, TJ; Thiessen, JD | 1 |
Alongi, P; Argiroffi, G; Baldari, S; Baratto, L; Bisdas, S; Califaretti, E; Ceci, F; De Vincentis, G; Del Sole, A; Evangelista, L; Frantellizzi, V; Iagaru, A; Laudicella, R; Quartuccio, N | 1 |
Brown, D; Fahey, FH; Fouladi, M; Kocak, M; Onar-Thomas, A; Poussaint, TY; Ricci, KI; Vajapeyam, S; Zukotynski, KA | 1 |
Ai, L; Chen, Q; Dai, J; Fan, D; Jiang, T; Lin, S; Qiao, Z; Wang, K; Zhao, X | 1 |
Arakawa, Y; Fushimi, Y; Miyamoto, S; Okada, T; Togashi, K; Yamamoto, A; Yamauchi, M | 1 |
Burrell, LD; Gillespie, DL; Horn, KP; Jensen, RL; Karsy, M; Yap, JT | 1 |
Cudalbu, C; Gruetter, R; Hamou, MF; Hegi, ME; Lai, M; Lanz, B; Poitry-Yamate, C; Vassallo, I | 1 |
Evangelou, E; Nihashi, T; Terasawa, T; Trikalinos, NA | 1 |
Chang, JH; Kim, D; Kim, S; Kim, SH; Yun, M | 1 |
Chang, JH; Kim, D; Kim, S; Kim, SH; Park, MA; Yun, M | 1 |
Fujii, N; Ideguchi, M; Ikeda, E; Ikeda, N; Kimura, T; Nishizaki, T; Ohno, M; Okamura, T; Shimabukuro, T; Suga, K; Tanaka, Y | 1 |
Aheer, D; Arora, G; Biswas, A; Garg, A; Hazari, PP; Kumar, R; Mishra, AK; Sharma, A; Sharma, P | 1 |
Abdollahi, A; Adeberg, S; Afshar-Oromieh, A; Bendszus, M; Bougatf, N; Debus, C; Debus, J; Floca, R; Haberkorn, U; Heiland, S; Knoll, M; Rieken, S; Waltenberger, M; Wick, W | 1 |
Chen, X; Iagaru, A; Ji, N; Lang, L; Li, D; Li, F; Niu, G; Qiao, Z; Zhang, J; Zhao, X; Zheng, K; Zhu, Z | 1 |
Achiha, T; Arita, H; Hashimoto, N; Hatazawa, J; Hirata, T; Kagawa, N; Kanemura, Y; Kinoshita, M; Kishima, H; Ogawa, K; Seo, Y; Shimosegawa, E; Suzuki, O; Tamari, K; Teshima, T; Umehara, T; Wakai, N | 1 |
Cui, R; Sun, H; Wang, J; Zhang, Y | 1 |
Albert, NL; Arbizu, J; Boellaard, R; Drzezga, A; Galldiks, N; la Fougère, C; Langen, KJ; Law, I; Lopci, E; Lowe, V; McConathy, J; Quick, HH; Sattler, B; Schuster, DM; Tonn, JC; Weller, M | 1 |
Chu, JP; Gao, SY; Jiang, L; Li, XB; Liu, SY; Ma, H; Song, YK; Tang, GH; Wang, JY; Wang, YL; Xiong, Y; Yang, ZY; Zhao, J | 1 |
Carideo, L; Cicone, F; Minniti, G; Scopinaro, F | 1 |
Momose, T; Mukasa, A; Soma, T; Takahashi, M; Tanaka, S; Yanagisawa, S | 1 |
Chiang, GC; Fine, HA; Kovanlikaya, I; Magge, R; Naeger, DM; Pisapia, DJ; Seligman, L | 1 |
Cho, KG; Jang, SJ; Kim, YI | 1 |
Alexiou, GA; Fotopoulos, AD; Jabbour, P; Katsanos, AH; Kyritsis, AP; Sioka, C | 1 |
Chua, B; Debowski, M; Goodman, S; Jeffree, RL; Lwin, Z; Shaw, TB; Thomas, P | 1 |
Cheng, X; Kong, Z; Li, J; Li, L; Lin, Y; Liu, Z; Ma, W; Tian, J; Wang, Y; Zhao, D | 1 |
Laymon, CM; Lieberman, FS; Mountz, JM; Oborski, MJ | 1 |
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
Cheng, X; Guo, X; Guo, Y; Ma, WB; Wang, RZ; Wang, Y; Zhong, DR | 1 |
Acou, M; D'Asseler, Y; De Ruyck, I; Goethals, I; Kalala, JP; Mertens, K; Van den Broecke, C; Van Hauwe, J | 1 |
Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D | 1 |
Chen, Z; Liu, Y; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
Dahabreh, IJ; Nihashi, T; Terasawa, T | 1 |
Galldiks, N; Langen, KJ | 1 |
Fougère, Cl; Hutterer, M; Jacobs, AH; Nowosielski, M; Putzer, D; Stockhammer, G; Virgolini, IJ | 1 |
Inoue, T; Kawahara, N; Kubota, K; Minamimoto, R; Murata, H; Nakanowatari, S; Ohtake, M; Suenaga, J; Tateishi, K; Tateishi, U | 1 |
Chang, KH; Choi, SH; Eun, Y; Kang, WJ; Kim, JH; Sohn, CH; Song, YS; Yoon, JH; Yun, TJ | 1 |
Guichard, SM; Keen, HG; Logie, A; Maynard, J; Odedra, R; Ricketts, SA; Shannon, AM; Wedge, SR | 1 |
Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S | 1 |
Boada, FE; Davis, DK; Imani, F; Lieberman, FS; Mountz, JM | 1 |
Antoch, G; Coenen, HH; Filss, CP; Fink, GR; Galldiks, N; Herzog, H; Langen, KJ; Sabel, M; Shah, NJ; Stoffels, G; Turowski, B; Wittsack, HJ; Zhang, K | 1 |
DiFranco, MD; Hutterer, M; Jacobs, AH; Nowosielski, M; Putzer, D; Recheis, W; Seiz, M; Stockhammer, G | 1 |
Hu, X; Li, W; Li, X; Ma, L; Wang, X; Xie, P | 1 |
Heiss, WD | 1 |
Autio, A; Gardberg, M; Heuser, VD; Käkelä, M; Kiviniemi, A; Knuuti, J; Kurkipuro, J; Li, XG; Liljenbäck, H; Minn, H; Roivainen, A; Sipilä, H; Ylä-Herttuala, S | 1 |
Bal, C; Julka, PK; Karunanithi, S; Kc, SS; Khangembam, BC; Kumar, R; Sharma, P | 1 |
Boyett, J; Fahey, F; Fouladi, M; Kocak, M; Kun, L; Poussaint, TY; Treves, T; Vajapeyam, S; Zukotynski, K | 1 |
Chen, X; Gao, Z; Ji, N; Kang, P; Li, D; Li, F; Liu, Z; Shi, J; Wang, J; Zhang, L; Zhao, X; Zhu, Z | 1 |
Wang, H; Xu, H; Xue, Y; Yu, W; Zhang, Y; Zhao, X | 2 |
Ciarmiello, A; Gaeta, MC; Giovannini, E; Lazzeri, P; Milano, A | 1 |
Arora, B; Dutta, D; Goda, JS; Gupta, T; Jalali, R; Juvekar, SL; Kurkure, P; Purandare, N; Rangarajan, V; Raut, N | 1 |
Bang, JI; Cheon, GJ; Choi, H; Chung, JK; Kang, KW; Kim, EE; Kim, YH; Lee, DS; Park, CK; Park, SH | 1 |
Chen, Z; Shi, X; Tang, G; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
Hoh, CK; Hoshi, H; Kanematsu, M; Kesari, S; Nozawa, A; Piccioni, D; Rivandi, AH | 1 |
Chen, L; Li, Z; Xu, G; Yu, Y; Zhang, H | 1 |
Mena, E; Meoded, A; Solnes, L; Subramaniam, RM; Wray, R | 1 |
Hwang, GY; Leung, GK; Li, LF; Lui, WM; Pu, JK; Taw, BB | 1 |
Dunet, V; Hottinger, A; Nicod-Lalonde, M; Pomoni, A; Prior, JO | 1 |
Carapella, CM; Chiaravalloti, A; Fabi, A; Floris, R; Marzi, S; Pace, A; Piludu, F; Schillaci, O; Terrenato, I; Vidiri, A; Villani, V | 1 |
Dankbaar, JW; De Keizer, B; Eppinga, W; Hendrikse, J; Robe, PA; Seute, T; Snijders, TJ | 1 |
Cama, A; Garrè, ML; Mascelli, S; Massollo, M; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Raso, A; Rossi, A | 1 |
Beal, K; Gavrilovic, I; Hatzoglou, V; Omuro, A; Peck, KK; Rubel, J; Schneider, T; Ulaner, G; Woo, KM; Yang, TJ; Young, RJ; Zhang, Z | 1 |
Babb, JS; Fine, H; Golfinos, JG; Jain, R; Kondziolka, D; Lee, J; Raad, RA; Sacconi, B | 1 |
Cabria, M; Garrè, ML; Morana, G; Piccardo, A; Rossi, A | 1 |
Baquero, M; Bassa, P; García-Garzon, JR; Riera, E; Soler, M; Villasboas-Rosciolesi, D | 1 |
Anees K, M; Jayaprakash, PG; Joy, A; Madhavan, J; Nair, S; Nanabala, R; Pillai, MR; Sasikumar, A | 1 |
Herholz, K | 2 |
Arai, T; Koyama, K; Momose, T; Mukasa, A; Soma, T; Takahashi, M | 1 |
Hatakeyama, T; Kaji, M; Kameyama, R; Kawai, N; Kimura, N; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S; Voulgaris, S | 1 |
Hatakeyama, T; Kameyama, R; Kawai, N; Kimura, N; Nishiyama, Y; Yamamoto, Y | 1 |
Alexopoulos, A; Lachhwani, D; Ruggieri, P; Talanow, R; Wu, G | 1 |
Amador, R; Galeano, I; Lucas, A; Martín, M; Martínez, JC; Prat, R; Reynés, G | 1 |
Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE | 1 |
Ament, C; Gonzalez, RG; Hochberg, FH; Kwong, K; Lev, MH; Mullins, ME; Ozsunar, Y; Schaefer, PW | 1 |
Haylock, B; Husband, D; Jenkinson, MD; Pietronigro, D; Shenoy, A; Smith, TS; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN | 1 |
Beer, AJ; Drzezga, A; Kläsner, BD; Krause, BJ | 1 |
Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F | 1 |
Hirata, K; Kobayashi, H; Murata, J; Shiga, T; Tanaka, S; Terasaka, S; Yamaguchi, S | 1 |
Chang, KH; Jung, HW; Kang, KW; Kim, YH; Lee, SH; Lim, YJ; Oh, SW; Park, CK | 1 |
Asaoka, K; Hirata, K; Kobayashi, H; Kubota, K; Murata, J; Narita, T; Shiga, S; Tanaka, S; Terasaka, S; Usui, R; Yamaguchi, S | 1 |
Kawai, N; Kudomi, N; Monden, T; Nishiyama, Y; Sasakawa, Y; Yamamoto, Y | 1 |
Bognar, L; Borbely, K; Fedorcsak, I; Kasler, M; Martos, J; Wintermark, M | 1 |
Burkholder, I; Combs, SE; Essig, M; Giesel, FL; Haberkorn, U; Henze, M; Kauczor, HU; Kroll, A; Meissner, M; Stieltjes, B; Tüttenberg, J; Vogt-Schaden, M; Weber, MA; Zimmer, F; Zoubaa, S | 1 |
Barboriak, DP; Friedman, HS; Paldino, MJ; Reardon, DA; Wong, TZ | 1 |
Boada, FE; Davis, DK; Deeb, EL; Imani, F; Lieberman, FS; Mountz, JM | 1 |
Dimitrakopoulou-Strauss, A; Eisenhut, M; Haberkorn, U; Schmieder, K; Seiz, M; Strauss, LG; Tuettenberg, J | 1 |
Alavi, A; Boyett, JM; Fahey, FH; Geyer, JR; Haas-Kogan, DA; Kocak, M; Kun, LE; Poussaint, TY; Shulkin, BL; Treves, ST; Vajapeyam, S; Wong, TZ; Zukotynski, KA | 1 |
Cheng, YK; Hsiao, IT; Lin, KJ; Wang, TC; Wey, SP; Yen, TC | 1 |
Bal, C; Julka, PK; Kumar, A; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
Aki, T; Asano, Y; Ito, T; Iwama, T; Miwa, K; Shinoda, J; Takenaka, S; Yokoyama, K | 1 |
Bandy, D; Carpenteri, D; Dvorchik, I; Etzl, M; Gieseking, A; Kaplan, A; Rosenfeld, A | 1 |
Bal, C; Julka, PK; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 2 |
Heiss, WD; Lanfermann, H; Raab, P | 1 |
Arita, H; Fujimoto, Y; Goto, T; Hashimoto, N; Hatazawa, J; Isohashi, K; Kagawa, N; Kinoshita, M; Kishima, H; Okita, Y; Saitoh, Y; Shimosegawa, E; Yoshimine, T | 1 |
Fadeev, NP; Golovtsova, MIu; Kartashev, AV; Kostenikov, NA; Tiushin, LA; Zykov, EM | 1 |
Barrie, M; Béquet-Boucard, C; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Mancini, J; Metellus, P; Mundler, O | 1 |
Maeda, M; Matsushima, N; Suzawa, N; Takeda, K; Umino, M; Yamada, T | 1 |
Li, DL; Li, HS; Wang, QS; Wu, HB; Xu, YK | 1 |
Barrie, M; Bequet-Boucard, C; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Mancini, J; Metellus, P; Mundler, O; Tabouret, E | 1 |
Hatakeyama, T; Kawai, N; Miyake, K; Okada, M; Shinomiya, A; Tamiya, T | 1 |
Lopez, WO; Mader, I; Nguyen, T; Nikkhah, G; Pinsker, MO; Reithmeier, T; Spehl, TS | 1 |
Alkonyi, B; Bahl, G; Barger, GR; Chakraborty, PK; Chugani, DC; Juhász, C; Kupsky, WJ; Mittal, S; Muzik, O; Robinette, NL | 1 |
Achten, E; Acou, M; Goethals, I; Mertens, K; Nuyts, R; Van den Broecke, C; Van Roost, D | 1 |
Boucher, KM; Butterfield, RI; Christian, PE; Enslow, MS; Heilbrun, ME; Hoffman, JM; Jensen, RL; Kadrmas, DJ; Morton, KA; Zollinger, LV | 1 |
Calabria, F; Schillaci, O | 1 |
Buchin, MP; Carpenter, CM; Cheng, Z; Gambhir, SS; Jiang, H; Liu, H; Pratx, G; Sun, C; Xing, L | 1 |
Asklund, T; Axelsson, J; Johansson, A; Karlsson, M; Larsson, A; Nyholm, T; Riklund, K | 1 |
Arita, H; Fujimoto, Y; Goto, T; Hashimoto, N; Hatazawa, J; Isohashi, K; Kagawa, N; Kinoshita, M; Kishima, H; Okita, Y; Shimosegawa, E; Watabe, T; Yoshimine, T | 1 |
Belka, C; Büsing, K; Eigenbrod, S; Ganswindt, U; Geisler, J; Jansen, N; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB | 1 |
Bal, C; Jacobs, MP; Mantil, JC; Narayanan, TK; Singhal, T | 1 |
Bourgeat, P; Coulthard, A; Crozier, S; Dowson, N; Fay, M; Gal, Y; Rose, S; Salvado, O; Thomas, P | 1 |
Bartenstein, P; Cumming, P; Egensperger, R; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; Kretzschmar, HA; la Fougère, C; Lutz, J; Pöpperl, G; Schwartz, C; Thon, N; Tonn, JC | 1 |
Göbel, G; Hutterer, M; Jacobs, AH; Jansen, NL; la Fougère, C; McCoy, M; Nowosielski, M; Putzer, D; Schocke, M; Seiz, M; Stockhammer, G; Trinka, E; Virgolini, IJ | 1 |
Hanzawa, H; Hatano, T; Kuge, Y; Kuno, N; Nishijima, K; Sakamoto, T; Tamaki, N; Zhao, S; Zhao, Y | 1 |
Gildehaus, FJ; Götz, C; Hahn, K; Pöpperl, G; Reulen, HJ; Tatsch, K; Yousry, TA | 1 |
Fenton, LZ; Foreman, NK; Madden, JR | 1 |
Bénard, F; Hustinx, R; Romsa, J | 1 |
Dittmar, C; Garlip, G; Heiss, WD; Jacobs, AH; Winkeler, A | 1 |
Bernstein, T; Christian, B; Dunigan, K; Hwang, DR; Jacobs, M; Kraus, G; Mantil, JC; Padma, MV; Ruppert, J; Said, S; Satter, M | 1 |
Adamsen, TC; Burrows, RC; Charlop, AW; Freeman, SD; Krohn, KA; Spence, AM; Wiseman, RW | 1 |
Chung, JK; Jeong, JM; Kim, SK; Lee, DS; Lee, MC; Lee, YJ | 1 |
Cobben, DC; de Vries, EF; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van Waarde, A | 1 |
Blasberg, R; Finn, R; Gelovani, JG; Miyagawa, T; Oku, T; Sasajima, T | 1 |
Könemann, S; Kopka, K; Pöpping, D; Riemann, B; Schober, O; Weckesser, M; Willich, N | 1 |
Brotchi, J; David, P; Goldman, S; Levivier, M; Massager, N; Pirotte, B; Salmon, I; Vandesteene, A; Wikler, D | 1 |
Bormans, G; Ceyssens, S; de Groot, T; Flamen, P; Menten, J; Mortelmans, L; Van Calenbergh, F; Van Laere, K | 1 |
Chung, JK; Im, SH; Jeong, JM; Jung, HW; Kim, DG; Kim, S; Lee, DS; Lee, MC | 1 |
Bachert, P; Henze, M; Kauczor, HU; Lichy, MP; Plathow, C; Schlemmer, HP | 1 |
Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Mankoff, DA; Minoshima, S; Muzi, M; O'Sullivan, SF; Pham, P; Spence, AM; Swanson, K | 1 |
Chen, LH; Chen, YR; Li, WX; Lin, YR | 1 |
Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitski, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
Branle, F; Brotchi, J; De Witte, O; Goldman, S; Oulad Ben Taib, N; Rorive, S | 1 |
Barrio, JR; Gambhir, SS; Herschman, HR; Namavari, M; Phelps, ME; Satyamurthy, N; Yaghoubi, SS | 1 |
Riemann, B; Schober, O | 1 |
Lengyel, Z; Molnar, P; Novak, L; Tron, L | 1 |
Brock, CS; Jones, T; Luthra, SK; Osman, S; Price, PM; Young, H | 1 |
Chang, CW; Chen, JC; Hwang, JJ; Hwang, LC; Lee, TW; Liu, RS; Wang, HE; Wu, SY | 1 |
Bergsneider, M; Chen, W; Cloughesy, T; Czernin, J; Kamdar, N; Liau, L; Mischel, P; Phelps, ME; Satyamurthy, N; Silverman, DH | 1 |
Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
Gildehaus, FJ; Goetz, C; Herms, J; Holtmannspötter, M; Koch, W; Kreth, FW; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC | 1 |
Fujibayashi, Y; Furukawa, T; Kado, H; Kawai, H; Kubota, T; Nakagawa, T; Takamatsu, S; Toyohara, J; Yonekura, Y | 1 |
Boethius, J; Ericson, K; Wang, SX | 1 |
Berlangieri, SU; Cher, LM; Fabinyi, G; Hannah, A; Lawrentschuk, N; Murone, C; O'Keefe, GJ; Papenfuss, A; Ramdave, S; Sachinidis, JI; Scott, AM | 1 |
Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT | 1 |
Brashears, J; Coleman, RE; Friedman, A; Friedman, HS; Gururangan, S; Halperin, EC; McLaughlin, CA; Provenzale, J; Quinn, J; Reardon, D; Vredenburgh, J; Watral, MA | 1 |
Borbély, K; Ericson, K; Gulyás, B; Nyáry, I; Tóth, M | 1 |
Carames, MA; Carreras, JL; Clavo, B; Domper, M; Hernandez, MA; Montz, R; Morera, J; Pinar, B; Robaina, F; Santullano, V | 1 |
Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Rommel, F; Sabel, M; Stoffels, G; Stummer, W | 1 |
Meyer, MA | 1 |
Barnett, CM; Brock, C; Bydder, GM; Charnley, N; Glaser, M; Matthews, J; Newlands, ES; Price, P; Swindell, R; West, CM | 1 |
Cheon, JE; Chi, JG; Chung, JK; Kim, IO; Kim, TJ; Kim, WS; Kwon, JW; Moon, SG; Wang, KC; Yeon, KM | 1 |
Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
Coenen, HH; Floeth, FW; Jansen, P; Langen, KJ; Pauleit, D; Reifenberger, G; Riemenschneider, MJ; Sabel, M; Steiger, HJ; Stoffels, G | 1 |
Hartmann, C; Plotkin, M; Stockhammer, F; Thomale, UW; Von Deimling, A | 1 |
de Jong, JR; Dierckx, RA; Elsinga, PH; Ishiwata, K; Shiba, K; van Waarde, A | 1 |
Chen, W | 1 |
Fortin, D; Larouche, A; Lecomte, R; Mathieu, D; Tsanaclis, AM | 1 |
Trón, L | 1 |
Chastagner, P; Fouyssac, F; Karcher, G; Pinel, S; Plenat, F; Poussier, S; Scigliano, S | 1 |
Gómez-Río, M; Llamas-Elvira, JM; López-Ramírez, E; Ramos-Font, C; Rodríguez-Fernández, A | 1 |
Dirven, CM; Geldof, AA; Gerritsen, WR; Idema, S; Lamfers, ML; van der Jagt, M; Vandertop, WP | 1 |
Atkinson, M; Fuerst, D; Guo, X; Johnson, R; Juhász, C; Kupsky, W; Shah, J; Watson, C | 1 |
Bizzi, A; Boiardi, A; Fariselli, L; Laguzzi, E; Lamperti, E; Maccagnano, E; Milanesi, I; Rudà, R; Salmaggi, A; Silvani, A; Soffietti, R; Trevisan, E | 1 |
Amthauer, H; Plotkin, M; Stockhammer, F; van Landeghem, FK; Woiciechowsky, C | 1 |
Iwama, T; Kato, T; Maruyama, T; Miwa, K; Muragaki, Y; Nakayama, N; Okumura, A; Shinoda, J; Yano, H; Yoshimura, S | 1 |
Aliaga, A; Assadian, S; Bedell, BJ; Del Maestro, RF; Evans, AC | 1 |
Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S | 1 |
Carrasquillo, JA; Larson, SM | 1 |
Bairamian, D; Barker, J; Brooks, RA; Di Chiro, G; Kornblith, PL; Mansi, L; Patronas, NJ; Smith, BH | 1 |
Frackowiak, RS; Gibbs, JM; Hatazawa, J; Jones, T; Palmer, AJ; Rhodes, CG; Thomas, DG; Wise, RJ | 1 |
Brooks, R; De La Paz, R; Di Chiro, G; Jabbari, B; Newmark, ME; Patronas, N; Sato, S; Theodore, WH | 1 |
Brooks, RA; DeLaPaz, RL; Di Chiro, G; Johnston, GS; Kessler, RM; Kornblith, PL; Kufta, CV; Manning, RG; Patronas, NJ; Smith, BH; Sokoloff, L; Wolf, AP | 1 |
Besser, M; Dexter, MA; Ell, J; Fulham, MJ; Parker, GD | 1 |
Go, KG; Heesters, MA; Kamman, RL; Mooyaart, EL; Paans, AM; Pruim, J; Vaalburg, W | 1 |
Balériaux, D; Bidaut, LM; Brotchi, J; Brucher, JM; Goldman, S; Levivier, M; Luxen, A; Pirotte, B; Stanus, E | 1 |
Delbeke, D; Jennings, MT; Kessler, RM; Lapidus, RL; Maciunas, RJ; Meyerowitz, C; Moots, PL | 1 |
Ishikawa, M; Ishizu, K; Magata, Y; Miyatake, S; Nishizawa, S; Okazawa, H; Sadato, N; Tamaki, N; Tsuchida, T; Yonekura, Y | 1 |
Anderson, JH; Barker, PB; Blackband, SJ; Conti, PS; Dannals, RF; Hilton, J; Natarajan, TK; Samphilipo, MA; Strandberg, JD; Wong, DF | 1 |
Hatazawa, J; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Uemura, K | 1 |
Ishikawa, M; Kikuchi, H; Miyatake, S; Nishizawa, S; Oda, Y; Yonekura, Y | 1 |
Ahmad, K; Endo, K; Hirano, T; Horikoshi, S; Inoue, T; Oriuchi, N; Sarwar, M; Shibasaki, T; Suzuki, H; Tamura, M; Tokunaga, M; Tomiyoshi, K; Watanabe, N | 1 |
Brotchi, J; Damhaut, P; De Witte, O; Goldman, S; Hildebrand, J; Levivier, M; Salmon, I; Violon, P; Wikler, D | 1 |
Deshmukh, A; Fischman, AJ; Gruber, M; Hochberg, FH; Palmer, EL; Scott, JA | 1 |
Hatazawa, J; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Uemura, K; Yasui, N | 1 |
Heiss, WD; Herholz, K; Lanfermann, H; Pietrzyk, U; Thiel, A; Wagner, R; Wienhard, K | 1 |
Barker, FG; Chang, SM; Pounds, TR; Prados, MD; Valk, PE | 1 |
Beaudouin, V; Chapon, F; Courtheoux, P; Creveuil, C; Derlon, JM; Houtteville, JP; Noël, MH; Petit-Taboué, MC | 1 |
Brotchi, J; Brucher, JM; Damhaut, P; Dethy, S; Goldman, S; Hildebrand, J; Levivier, M; Pirotte, B; Wikler, D | 1 |
Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G | 1 |
Brotchi, J; Damhaut, P; De Witte, O; Goldman, S; Hildebrand, J; Levivier, M; Monclus, M; Pirotte, B; Wikler, D | 1 |
Tsuyuguchi, N | 1 |
Bryan, RN | 1 |
Hausmann, O; Leenders, KL; Maguire, RP; Missimer, J; Müller-Brand, J; Otte, A; Radü, EW; Roelcke, U; von Ammon, K | 1 |
Degueldre, C; Del Fiore, G; Deprez, M; Kaschten, B; Luxen, A; Reznik, M; Sadzot, B; Stevenaert, A | 1 |
Hirano, T; Horikoshi, S; Kurihara, H; Ono, N; Oriuchi, N; Shibasaki, T; Tamura, M; Zama, A | 1 |
Bauer, B; Heiss, WD; Herholz, K; Hölzer, T; Pietrzyk, U; Schröder, R; Sturm, V; Treuer, H; Voges, J; Würker, M | 1 |
Bader, JB; Feiden, W; Kirsch, CM; Kremp, S; Moringlane, JR; Samnick, S; Schaefer, A | 1 |
Barrio, JR; Bauer, E; Berk, AJ; Cherry, SR; Gambhir, SS; Green, LA; Herschman, HR; Iyer, M; MacLaren, DC; Namavari, M; Nguyen, K; Phelps, ME; Satyamurthy, N; Wu, L | 1 |
Stevens, H; Stokkel, M; Taphoorn, M; Van Rijk, P | 1 |
Dillon, WP; Nelson, SJ; Vigneron, DB | 1 |
Otte, A | 1 |
Brock, CS; Evans, H; Matthews, J; Newlands, ES; O'Reilly, SM; Osman, S; Price, PM; Young, H | 1 |
Burrows, RC; Freeman, SD; Graham, MM; Krohn, KA; Link, JM; Muzi, M; Spence, AM; Wiseman, RW | 1 |
Pauwels, EK; Stokkel, MP; van der Hiel, B | 1 |
Enomoto, S; Oku, N; Takeda, A; Tamano, H | 1 |
Jeong, JH; Kim, GM; Na, DL; Yoon, SJ | 1 |
Derlon, JM | 1 |
Adonai, N; Gambhir, SS; Iyer, M; McCarthy, DW; McCarthy, T; Nguyen, KN; Phelps, ME; Toyokuni, T; Walsh, J | 1 |
Eichhorn, K; Freitag, P; Gratzl, O; Hofer, S; Maecke, R; Merlo, A; Mueller-Brand, J; Probst, A; Reubi, JC; Schumacher, T; Wasner, M; Zimmerer, S | 1 |
Chung, JK; Jeong, JM; Jung, HW; Kim, SK; Kim, YK; Lee, DS; Lee, MC; Lee, YJ; Paek, S; Yeo, JS | 1 |
Eary, JF; Freeman, SD; Graham, MM; Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Mankoff, DA; Muzi, M; O'Sullivan, F; Spence, AM | 1 |
Kessler, RM; Maciunas, RJ; Mandava, V; Maurer, C; Smith, G; Watt, G | 1 |
Alagona, P; Cacciatore, R; Eikman, EA; Zangara, L | 1 |
Heiss, WD; Herholz, K; Rudolf, J | 1 |
denHollander, JA; Friedmann, G; Heindel, W; Heiss, WD; Herholz, K; Kugel, H; Luyten, PR; Pietrzyk, U; Voges, J | 1 |
Ishikawa, M; Iwasaki, Y; Kikuchi, H; Mukai, T; Nagata, I; Nishizawa, S; Taki, W; Yamagata, S; Yonekura, Y | 1 |
Burger, PC; Coleman, RE; Friedman, AH; Glantz, MJ; Hanson, MW; Herndon, JE; Hoffman, JM; Meisler, WJ; Schold, SC | 1 |
Rozental, JM | 1 |
Algan, O; Hanson, JM; Kinsella, TJ; Levin, AB; Levine, RL; Mehta, MP; Mendoza, M; Nickles, RJ; Rozental, JM; Schrader, DA | 1 |
Alavi, A; Alavi, JB; Kim, CK; Reivich, M | 1 |
Levine, RL; Nickles, RJ; Rozental, JM | 1 |
Maker, HS | 1 |
Darling, JL; Gill, SS; Parkins, CS; Thomas, DG; Wilson, CB | 1 |
Ishikawa, M; Kikuchi, H; Nishizawa, S; Yonekura, Y | 1 |
Alger, JR; Bizzi, A; Black, JL; DeSouza, BX; Duhaney, MO; Frank, JA; Fulham, MJ; Inscoe, SW; Moonen, CT; van Zijl, PC | 1 |
Bunke, J; Friedmann, G; Heindel, W; Heiss, WD; Herholz, K; Jeske, J; Rudolf, J | 1 |
Dobkin, JA; Hanson, JM; Levine, RL; Nickles, RJ; Rozental, JM | 1 |
Budinger, TF; Derenzo, SE; Geyer, AB; Huesman, RH; Jagust, WJ; Valk, PE | 1 |
Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Suda, Y; Uemura, K | 1 |
Dobkin, JA; Levine, RL; Nickles, RJ; Rozental, JM | 1 |
Heindel, W; Heiss, WD; Herholz, K; Jeske, J | 1 |
Hino, A; Hirakawa, K; Imahori, Y; Mizukawa, N; Nakahashi, H; Oki, F; Tenjin, H; Yamashita, M; Yano, I; Yoshino, E | 1 |
Budinger, TF; Doyle, WK; Gutin, PH; Levin, VA; Silver, P; Valk, PE | 1 |
Higano, S; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Sasaki, H; Shishido, F; Uemura, K; Yamaguchi, T | 1 |
Kowada, M; Mineura, K; Ogawa, T; Shishido, F; Uemura, K; Yasuda, T | 1 |
Kwee, IL; Nakada, T | 1 |
Alavi, A; Alavi, JB; Chawluk, J; Hickey, W; Kushner, M; Powe, J; Reivich, M | 1 |
Heiss, WD; Herholz, K; Pawlik, G; Staffen, W; Wagner, R; Wienhard, K; Ziffling, P | 1 |
Blacklock, JB; Di Chiro, G; Larson, SM; Oldfield, EH; Theodore, W; Tran, D; Wright, DC | 1 |
Kanno, I; Miura, S; Murakami, M; Sasaki, H; Shishido, F; Takahashi, K; Uemura, K | 1 |
Di Chiro, G | 1 |
Cummins, CJ; Graham, JF; Kornblith, PL; Smith, BH | 1 |
28 review(s) available for fluorodeoxyglucose f18 and Glioma
Article | Year |
---|---|
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Facts and Fictions About [
Topics: Amino Acids; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography | 2022 |
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.
Topics: Amino Acids; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.
Topics: Artificial Intelligence; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Research Design | 2018 |
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Neoplasm Grading; Positron-Emission Tomography; Tyrosine | 2019 |
PET in the clinical management of glioma: evidence map.
Topics: Biopsy; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2015 |
[PET in gliomas. Overview of current studies].
Topics: Brain Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Clinical applications of choline PET/CT in brain tumors.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Glioma; Half-Life; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2015 |
(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
Topics: Brain Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Brain Tumors: An Update on Clinical PET Research in Gliomas.
Topics: Biomarkers, Tumor; Brain Neoplasms; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography | 2017 |
PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.
Topics: Animals; Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radioactive Tracers | 2010 |
The pre-requisite of a second-generation glioma PET biomarker.
Topics: Biomarkers; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Multimodality assessment of brain tumors and tumor recurrence.
Topics: Amino Acids; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Education, Medical, Continuing; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Hypoxia, Brain; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2011 |
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Topics: Brain; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Glioma; Methionine; Methyltyrosines; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Molecular imaging of gliomas.
Topics: Animals; Brain Neoplasms; Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Genetic Markers; Genetic Therapy; Genetic Vectors; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Molecular Biology; Radiopharmaceuticals; Signal Transduction; Tomography, Emission-Computed | 2002 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Clinical applications of PET in brain tumors.
Topics: Adult; Amino Acids; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Nuclear oncology 1984.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bleomycin; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Liver Neoplasms; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins; Neoplasms; Tomography, Emission-Computed | 1984 |
Positron emission tomography and brain tumours.
Topics: Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.
Topics: Animals; Astrocytoma; Blood Volume; Brachytherapy; Brain; Brain Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Radiography; Radiosurgery; Tomography, Emission-Computed | 1999 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Central Nervous System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Rats; Tomography, Emission-Computed | 2001 |
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
Topics: Blood Glucose; Brain Neoplasms; Child; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Glioma; Humans; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
15 trial(s) available for fluorodeoxyglucose f18 and Glioma
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
Topics: Brain Stem Neoplasms; Child; Disease-Free Survival; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Research Report; Treatment Outcome | 2013 |
Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Mapping; Brain Neoplasms; Carmustine; Cerebrovascular Circulation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Injections, Intramuscular; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Thallium; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Shortening the duration of [18F]FDG PET brain examination for diagnosis of brain glioma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors | 2011 |
Detection of recurrence in glioma: a comparative prospective study between Tc-99m GHA SPECT and F-18 FDG PET/CT.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Prospective Studies; Recurrence; Sugar Acids; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2011 |
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.
Topics: Adult; Aged; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Recurrence; Young Adult | 2012 |
Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.
Topics: Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioma; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stereotaxic Techniques; Surgery, Computer-Assisted; Tomography, Emission-Computed | 2004 |
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Male; Middle Aged; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sample.
Topics: Arteries; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiopharmaceuticals; Temozolomide; Tomography, Emission-Computed | 2000 |
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Topics: Adult; Aged; Brachytherapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Injections, Intralesional; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Receptors, Somatostatin; Sensitivity and Specificity; Treatment Outcome; World Health Organization; Yttrium Radioisotopes | 2002 |
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2002 |
224 other study(ies) available for fluorodeoxyglucose f18 and Glioma
Article | Year |
---|---|
First-in-human assessment of the novel LAT1 targeting PET probe
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Large Neutral Amino Acid-Transporter 1; Male; Molecular Probes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2022 |
Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study.
Topics: Animals; Fluorodeoxyglucose F18; Glioma; Humans; Mutation; Positron-Emission Tomography; Rats; Receptors, GABA | 2022 |
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
Topics: Amino Acids; Child; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Multicenter clinical radiomics-integrated model based on [
Topics: alpha-Thalassemia; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Intellectual Disability; Magnetic Resonance Imaging; Mutation; Retrospective Studies; X-linked Nuclear Protein | 2023 |
Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and
Topics: Astrocytoma; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Isocitrate Dehydrogenase; Mutation; Perfusion; Retrospective Studies; Telomerase | 2023 |
Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Topics: Fluorodeoxyglucose F18; Glioma; Humans; Machine Learning; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Retrospective Studies | 2023 |
Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis.
Topics: Autoimmune Diseases of the Nervous System; Convalescence; Fluorodeoxyglucose F18; Glioma; Humans; Leucine; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2023 |
68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Young Adult | 2023 |
Topics: Adult; Aged; Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Promoter Regions, Genetic; Radiopharmaceuticals; Tumor Suppressor Proteins | 2019 |
What Does Reduced FDG Uptake Mean in High-Grade Gliomas?
Topics: Biological Transport; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography | 2019 |
Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model.
Topics: Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 2020 |
Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Hypoxia; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2020 |
Can FDG-PET/MR help to overcome limitations of sequential MRI and PET-FDG for differential diagnosis between recurrence/progression and radionecrosis of high-grade gliomas?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.
Topics: Brain Neoplasms; Case-Control Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Glucose; Humans; Isocitrate Dehydrogenase; Mutation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tumor Cells, Cultured | 2021 |
Efficacy of Positron Emission Tomography in distinguishing brain tumours from inflammation.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, GABA | 2020 |
Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Pyruvic Acid; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, X-Ray Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Correlation of
Topics: Adolescent; Brain Stem Neoplasms; Child; Child, Preschool; Diffusion; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2017 |
A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.
Topics: Brain Neoplasms; Diagnosis, Differential; Discriminant Analysis; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2017 |
Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging.
Topics: Animals; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Humans; Luciferases; Luminescent Proteins; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2018 |
In vivo characterization of brain metabolism by
Topics: Adaptor Proteins, Signal Transducing; Animals; Aspartic Acid; Brain; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glioma; Glucose; Glutamic Acid; Humans; Male; Mice; Neoplasm Transplantation; Oxidation-Reduction; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Repressor Proteins | 2018 |
Prediction of Overall Survival Based on Isocitrate Dehydrogenase 1 Mutation and 18F-FDG Uptake on PET/CT in Patients With Cerebral Gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis | 2018 |
The roles of
Topics: Acetates; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Cell Differentiation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2018 |
A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carbon Radioisotopes; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Neurosurgical Procedures; Positron-Emission Tomography; Prospective Studies; Surgery, Computer-Assisted; Young Adult | 2018 |
99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Technetium | 2018 |
Impact of
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2018 |
Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
Topics: Adult; Coordination Complexes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Treatment Outcome; Young Adult | 2019 |
Hypermetabolism Caused by Seizure Mimicking Tumor Recurrence.
Topics: Adult; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seizures | 2018 |
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
Topics: Adult; Amino Acids; Child; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Isotope Labeling; Nuclear Medicine; Positron-Emission Tomography; Practice Guidelines as Topic; Quality Control; Recurrence; Reference Standards; Research Design; Societies, Medical | 2019 |
Radiosynthesis and Preliminary Biological Evaluation of
Topics: Animals; Cell Line, Tumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Scorpion Venoms; Tissue Distribution; Transplantation, Heterologous | 2018 |
The mean striatal
Topics: Amino Acids; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Tumor Burden | 2019 |
Pattern of FDG and MET Distribution in High- and Low-Grade Gliomas on PET Images.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies | 2019 |
Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
Comparison of dual-time point 18F-FDG PET/CT tumor-to-background ratio, intraoperative 5-aminolevulinic acid fluorescence scale, and Ki-67 index in high-grade glioma.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Brain Neoplasms; Cell Proliferation; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Glioma; Humans; Intraoperative Period; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma.
Topics: Adult; Algorithms; Brain Neoplasms; Cell Proliferation; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.
Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography | 2013 |
[Application of positron-emission tomography-magnetic resonance imaging fusion in biopsy and resection of gliomas].
Topics: Adult; Aged; Biopsy; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Young Adult | 2013 |
Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Reproducibility of Results; Stereotaxic Techniques | 2013 |
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine | 2013 |
The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas.
Topics: Adolescent; Adult; Aged; Ammonia; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Young Adult | 2013 |
Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2013 |
Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2013 |
(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thiosemicarbazones; Young Adult | 2014 |
Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2014 |
Examining changes in [18 F]FDG and [18 F]FLT uptake in U87-MG glioma xenografts as early response biomarkers to treatment with the dual mTOR1/2 inhibitor AZD8055.
Topics: Animals; Biomarkers, Tumor; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Mice; Mice, Nude; Morpholines; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2014 |
Molecular and metabolic pattern classification for detection of brain glioma progression.
Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Support Vector Machine | 2014 |
Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2014 |
An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2014 |
Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
Topics: Animals; Autoradiography; Brain; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Mice; Mice, Nude; Muscle, Skeletal; Neoplasm Proteins; Neoplasm Transplantation; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Receptors, Somatostatin; Tomography, X-Ray Computed | 2014 |
Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
Topics: Adolescent; Adult; Ammonia; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
(68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.
Topics: Adult; Aged; Antigens, CD34; Brain; Brain Neoplasms; Choroid Plexus; Coordination Complexes; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Immunohistochemistry; Integrin alphaVbeta3; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Peptides, Cyclic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
Fluorine-18-deoxyglucose positron emission tomography/computed tomography with Ki67 and GLUT-1 immunohistochemistry for evaluation of the radiosensitization effect of oleanolic acid on C6 rat gliomas.
Topics: Animals; Biological Transport; Cell Count; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioma; Glucose Transporter Type 1; Immunohistochemistry; Ki-67 Antigen; Male; Multimodal Imaging; Muscles; Oleanolic Acid; Positron-Emission Tomography; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed | 2015 |
¹⁸F-fluorodeoxyglucose and ¹¹C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.
Topics: Adolescent; Adult; Aged; Child; DNA Methylation; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Grading; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Prognosis; Promoter Regions, Genetic; Retrospective Studies; Young Adult | 2015 |
13N-ammonia combined with 18F-FDG could discriminate between necrotic high-grade gliomas and brain abscess.
Topics: Adult; Aged; Ammonia; Brain Abscess; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Nitrogen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
Topics: Adult; Aged; Biological Transport; Blood Glucose; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm, Residual; Positron-Emission Tomography; Recurrence | 2015 |
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2015 |
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Topics: Adult; Aged; Brain Neoplasms; Demography; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Young Adult | 2015 |
The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cohort Studies; Disease Progression; Drug Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiotherapy; ROC Curve | 2015 |
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Sensitivity and Specificity; Supratentorial Neoplasms | 2015 |
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries | 2016 |
Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Perfusion Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2016 |
18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors.
Topics: Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Topics: Animals; Benzoquinones; Cell Line, Tumor; Down-Regulation; Fluorodeoxyglucose F18; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Misonidazole; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Hypoxia | 2016 |
A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake.
Topics: Adult; Carbon Radioisotopes; Central Nervous System Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Topics: Adult; Aged; Brain Neoplasms; Child; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Glioma; Humans; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2017 |
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using
Topics: Adult; Algorithms; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values | 2017 |
11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography | 2008 |
Imaging in glioma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Technetium Tc99m tetrofosmin single-photon emission CT for the assessment of glioma proliferation.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glioma; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Kinetics; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2009 |
PET manifestation in different types of pathology in epilepsy.
Topics: Adolescent; Adult; Child; Child, Preschool; Epilepsy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Infant; Infant, Newborn; Male; Middle Aged; Positron-Emission Tomography; Sclerosis; Young Adult | 2009 |
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2010 |
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2010 |
Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Topics: Adult; Aged; Brain Injuries; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2010 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2010 |
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine | 2010 |
Detection of histological anaplasia in gliomas with oligodendroglial components using positron emission tomography with (18)F-FDG and (11)C-methionine: report of two cases.
Topics: Adult; Anaplasia; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Oligodendroglia; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2011 |
Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy | 2010 |
[Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals | 2010 |
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels; Stereotaxic Techniques | 2010 |
Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2011 |
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
Topics: Adult; Aged; Brain; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography | 2012 |
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.
Topics: Bombesin; Discriminant Analysis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Positron-Emission Tomography; Recurrence | 2011 |
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
Topics: Adolescent; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results | 2011 |
Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging.
Topics: Animals; Autoradiography; Brain Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Locomotion; Male; Nervous System Diseases; Neurologic Examination; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Survival Analysis; Touch; Visual Perception | 2011 |
F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methionine; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2011 |
Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.
Topics: Adolescent; Brain Stem Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2011 |
F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; India; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
Imaging ¹⁸F-fluorodeoxy glucose/¹¹C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema.
Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Meningioma; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
[Potential of PET in the diagnosis and the assessment of treatment effectiveness in progressive malignant glioma].
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.
Topics: Adult; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2012 |
Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Child; Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Female; Fluorodeoxyglucose F18; Glioma; Humans; Irinotecan; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Linear Models; Male; Methionine; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Statistics, Nonparametric | 2012 |
Bevacizumab as salvage therapy for progressive brain stem gliomas.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Astrocytoma; Bevacizumab; Brain Stem Neoplasms; Combined Modality Therapy; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy | 2013 |
Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; ROC Curve; Tryptophan | 2012 |
Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging.
Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glioma; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Positron-Emission Tomography | 2012 |
Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT.
Topics: Cerebellar Diseases; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Radionuclide Imaging; Recurrence | 2012 |
Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study.
Topics: Animals; Endoscopy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioma; Intraoperative Period; Luminescent Measurements; Mice; Molecular Imaging; Phantoms, Imaging; Positron-Emission Tomography | 2012 |
Evaluation of an attenuation correction method for PET/MR imaging of the head based on substitute CT images.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Models, Statistical; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Regression Analysis; Tomography, X-Ray Computed | 2013 |
A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltration.
Topics: Adult; Aged; Biological Transport; Brain; Cell Count; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography | 2012 |
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tyrosine; Young Adult | 2012 |
11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.
Topics: Adult; Child; Contrast Media; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2012 |
Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Female; Fluorodeoxyglucose F18; Glioma; Humans; Levodopa; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2013 |
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Fluorodeoxyglucose F18; Glioma; Humans; Loss of Heterozygosity; Male; Middle Aged; Neoplasm Grading; Oligodendroglia; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2013 |
Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.
Topics: Animals; Autoradiography; Biological Transport; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glucose Transporter Type 1; Hexokinase; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Wistar; Tissue Distribution | 2013 |
[Initial experiences with adjuvant locoregional radioimmunotherapy using 131I-labeled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)].
Topics: Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Iodine Radioisotopes; Male; Middle Aged; Radioimmunotherapy; Radioisotopes; Recurrence; Survival Analysis; Tenascin; Time Factors; Tomography, Emission-Computed | 2002 |
Brain stem glioma in a child: false diagnosis of radiation necrosis with FDG PET.
Topics: Brain Stem; Brain Stem Neoplasms; Child; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Necrosis; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Prediction of pathology and survival by FDG PET in gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Statistics as Topic; Survival Rate; Tomography, Emission-Computed | 2003 |
[18F]-2-fluoro-2-deoxyglucose transport kinetics as a function of extracellular glucose concentration in malignant glioma, fibroblast and macrophage cells in vitro.
Topics: Animals; Biomarkers, Tumor; Cell Line; Cell Line, Tumor; Culture Media; Extracellular Space; Fibroblasts; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Macrophages; Metabolic Clearance Rate; Mice; Radionuclide Imaging; Radiopharmaceuticals; Rats | 2004 |
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Inflammation; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Rodentia; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2004 |
Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.
Topics: Amino Acid Transport Systems; Aminoisobutyric Acids; Carbon Radioisotopes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
Early effects of irradiation on [(123)I]-IMT and [(18)F]-FDG uptake in rat C6 glioma cells.
Topics: Animals; Biological Transport; Cell Division; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Iodine Radioisotopes; Methyltyrosines; Radiography; Radiopharmaceuticals; Rats | 2004 |
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Topics: Adolescent; Adult; Aged; Belgium; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Korea; Male; Methionine; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
[Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Topics: Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
[Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
Topics: Adult; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
Topics: Adult; Aged; Alleles; Blood-Brain Barrier; Brain; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lasers; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
[Contribution of PET to the management of patients with low-grade glioma].
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.
Topics: Animals; Cell Line, Tumor; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Ganciclovir; Gene Expression; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Glioma; Guanine; Herpesvirus 1, Human; Image Processing, Computer-Assisted; Mice; Mice, Nude; Positron-Emission Tomography; Rats; Thymidine Kinase; Time Factors; Transplantation, Heterologous | 2005 |
Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.
Topics: Amino Acid Transport Systems; Aminoisobutyric Acids; Carbon Radioisotopes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemma.
Topics: Adult; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Severity of Illness Index | 2005 |
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Topics: Animals; Boron Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glycopeptides; Metabolic Clearance Rate; Molecular Probe Techniques; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine | 2005 |
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2005 |
Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2005 |
Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survival; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Glioma; Nimustine; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Treatment Outcome | 2006 |
FDG-PET on irradiated brain tumor: ten years' summary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma; Child; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2006 |
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine | 2006 |
Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.
Topics: Adolescent; Brain Neoplasms; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Incidence; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Spinal Cord Neoplasms; Survival Analysis | 2006 |
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Topics: Adolescent; Adult; Aged; Biopsy; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve | 2006 |
Modification of glucose metabolism in brain tumors by using cervical spinal cord stimulation.
Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cerebral Cortex; Electric Stimulation Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oxygen Consumption; Positron-Emission Tomography; Regional Blood Flow; Spinal Cord | 2006 |
18F-FET PET differentiation of ring-enhancing brain lesions.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Positron-emission tomography in cancer therapy.
Topics: Fluorodeoxyglucose F18; Glioma; Humans; Neoplasms; Positron-Emission Tomography | 2006 |
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Temozolomide; Treatment Outcome | 2006 |
Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation.
Topics: Adolescent; Brain Stem Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2006 |
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies | 2007 |
Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Topics: Adult; Aged; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Fluorodeoxyglucose F18; Glioma; Humans; Loss of Heterozygosity; Male; Microsatellite Repeats; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2007 |
Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Carbon Radioisotopes; Doxorubicin; Fluorodeoxyglucose F18; Glioma; Male; Piperazines; Positron-Emission Tomography; Rats; Rats, Wistar; Receptors, sigma; Tissue Distribution | 2007 |
Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.
Topics: Animals; Biomarkers, Tumor; Brain; Brain Neoplasms; Catheters, Indwelling; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Energy Metabolism; Fluorodeoxyglucose F18; Glioma; Immunohistochemistry; Infusion Pumps, Implantable; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Transplantation; Nerve Tissue Proteins; Positron-Emission Tomography; Rats; Rats, Inbred F344; Survival Rate | 2007 |
Re. "Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11 C-methionine in the determination of malignancy of gliomas" by Borbély et al. [J Neurol Sci 246 (2006) 85-94].
Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Nervous System Neoplasms; Positron-Emission Tomography | 2007 |
Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts.
Topics: Anemia; Animals; Autoradiography; Electrodes; Erythropoietin; Fluorodeoxyglucose F18; Glioma; Hemoglobins; Humans; Hypoxia; Mice; Mice, Nude; Muscle, Skeletal; Neoplasm Transplantation; Nitroimidazoles; Recombinant Proteins; Transplantation, Heterologous | 2008 |
Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
Evaluation of adenoviral oncolytic effect on glioma spheroids by 18F-DG positron-emission tomography.
Topics: Adenoviridae; Fluorodeoxyglucose F18; Glioma; Humans; Oncolytic Virotherapy; Positron-Emission Tomography; Spheroids, Cellular; Tumor Cells, Cultured | 2007 |
Paradoxical imaging findings in cerebral gliomas.
Topics: Adult; Brain Neoplasms; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Natural history and management of brainstem gliomas in adults. A retrospective Italian study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain; Brain Stem Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Spinal Cord; Survival Analysis; Treatment Outcome | 2008 |
Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas.
Topics: Adult; Aged; Blood Vessels; Brain Neoplasms; Cell Count; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glioma; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
FDG-PET imaging for the evaluation of antiglioma agents in a rat model.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Glucose Transporter Type 1; Immunohistochemistry; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley | 2008 |
99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors.
Topics: Animals; Astrocytoma; Blood-Brain Barrier; Brain; Central Nervous System Diseases; Deoxyglucose; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Ischemia; Phosphoric Monoester Hydrolases; Tomography, Emission-Computed | 1984 |
In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
Topics: Adult; Brain; Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Oxygen Consumption; Oxygen Radioisotopes; Tomography, Emission-Computed | 1983 |
EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
Topics: Adult; Brain Neoplasms; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Electroencephalography; Fluorine; Fluorodeoxyglucose F18; Glioma; Humans; Intracranial Pressure; Radioisotopes; Radionuclide Imaging; Thalamus; Tomography, X-Ray Computed | 1983 |
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Tomography, Emission-Computed | 1982 |
MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri.
Topics: Adolescent; Blood Glucose; Brain Neoplasms; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Neurologic Examination; Psychosurgery; Temporal Lobe; Tomography, Emission-Computed | 1995 |
Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Edema; Carbon Radioisotopes; Creatine; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Lactates; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Phosphorylcholine; Supratentorial Neoplasms; Tomography, Emission-Computed; Tyrosine | 1995 |
Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Topics: Adult; Aged; Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Proteins; Stereotaxic Techniques; Tomography, Emission-Computed | 1995 |
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Effects of hyperglycemia on FDG uptake in human brain and glioma.
Topics: Adult; Aged; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1994 |
Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
Topics: Animals; Brain; Brain Neoplasms; Deoxyglucose; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Neoplasm Transplantation; Regression Analysis; Tomography, Emission-Computed | 1994 |
Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Child; Combined Modality Therapy; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Survival Rate; Tomography, Emission-Computed | 1994 |
Glucose consumption in recurrent gliomas.
Topics: Adult; Animals; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Life Tables; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Topics: Brain Neoplasms; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
Topics: Adolescent; Adult; Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Ganglioglioma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Survival Rate; Tomography, Emission-Computed | 1996 |
Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Retrospective Studies; Tomography, Emission-Computed | 1996 |
Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Topics: Blood Glucose; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Image Processing, Computer-Assisted; Meningeal Neoplasms; Meningioma; Methionine; Tomography, Emission-Computed | 1996 |
F-Dopa as an amino acid tracer to detect brain tumors.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Oxygen Radioisotopes; Tomography, Emission-Computed; Water | 1996 |
18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Radionuclide Imaging; Survival Analysis | 1997 |
The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Topics: Adult; Aged; Amino Acids; Astrocytoma; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Oligodendroglioma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Topics: Adult; Aged; Biopsy, Needle; Brain; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Stereotaxic Techniques; Tomography, Emission-Computed | 1997 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Cell Division; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Ki-67 Antigen; Kinetics; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
What's your favorite PET story?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.
Topics: Adult; Animals; Brain Neoplasms; Cerebellum; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Methionine; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Topics: Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 1998 |
Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.
Topics: Astrocytoma; Blood Glucose; Brain Neoplasms; Cell Division; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Oligodendroglioma; Sensitivity and Specificity; Survival Rate; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
Topics: Adult; Brachytherapy; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Iodine Radioisotopes; Male; Methionine; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Topics: Adult; Aged; Astrocytoma; Biopsy; Brain; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography.
Topics: Animals; Fluorodeoxyglucose F18; Ganciclovir; Genes, Reporter; Genetic Therapy; Glioma; Herpesvirus 1, Human; Humans; Liver; Mice; Mice, Transgenic; Radiopharmaceuticals; Rats; Recombinant Proteins; Thymidine Kinase; Tomography, Emission-Computed; Transcription, Genetic; Transfection; Tritium; Tumor Cells, Cultured | 1999 |
Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Topics: Adult; Astrocytoma; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Oligodendroglioma; Pilot Projects; Radiation Injuries; Radiography; Radiopharmaceuticals; Radiotherapy; Recurrence; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Cerebral deafferentiation in operated gliomas as a predictor for malignancy?
Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors.
Topics: Animals; Brain Neoplasms; Cattle; Fluorodeoxyglucose F18; Glioma; Hexokinase; Humans; Isoenzymes; Kinetics; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tomography, Emission-Computed; Tumor Cells, Cultured | 2001 |
Zinc-65 imaging of rat brain tumors.
Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Carbon Radioisotopes; Chlorides; Fluorodeoxyglucose F18; Glioma; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Zinc Compounds; Zinc Radioisotopes | 2001 |
Neglect in radial and vertical axes after a unilateral left temporo-occipital lesion.
Topics: Aged; Aged, 80 and over; Agnosia; Aphasia, Wernicke; Apraxia, Ideomotor; Brain Neoplasms; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glioma; Hemianopsia; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Occipital Lobe; Orientation; Perceptual Disorders; Temporal Lobe; Tomography, Emission-Computed | 2001 |
[Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
Topics: Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Methionine; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.
Topics: Animals; Cell Movement; Copper Radioisotopes; Fluorodeoxyglucose F18; Glioma; Male; Mice; Mice, Nude; Organometallic Compounds; Rats; Thiosemicarbazones; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Topics: Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Meningeal Neoplasms; Meningioma; Methionine; Mitotic Index; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography imaging-directed stereotactic neurosurgery.
Topics: Astrocytoma; Biopsy; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Stereotaxic Techniques; Tomography, Emission-Computed | 1992 |
Positron emission tomography in clinical practice.
Topics: Adult; Brain Neoplasms; Child; Coronary Disease; Deoxyglucose; Epilepsy, Complex Partial; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Tomography, Emission-Computed | 1992 |
FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Topics: Adult; Biological Transport; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Phosphorylation; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Topics: Adult; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Glycolysis; Humans; Lactates; Lactic Acid; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1992 |
Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Topics: Adult; Aged; Analysis of Variance; Autoradiography; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1990 |
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Dexamethasone; Epilepsy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Postoperative Period; Radiation Injuries; Time Factors; Tomography, Emission-Computed | 1991 |
Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
Topics: Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Kidney Neoplasms; Melanoma; Stereotaxic Techniques; Tomography, Emission-Computed | 1991 |
New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
Topics: Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Regression Analysis; Survival Analysis; Tomography, Emission-Computed | 1991 |
Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
Topics: Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Prognosis; Tomography, Emission-Computed | 1991 |
Effect of chemotherapy on glioma metabolism.
Topics: Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans | 1991 |
Use of relocatable stereotactic frame to integrate positron emission tomography and computed tomography images: application in human malignant brain tumours.
Topics: Antigens, Surface; Biomarkers, Tumor; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Lymphoma; Models, Anatomic; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1990 |
Evaluation of glucose transport in malignant glioma by PET.
Topics: Biological Transport; Cerebral Cortex; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Tomography, Emission-Computed | 1990 |
Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Tomography, Emission-Computed | 1990 |
Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phosphorus; Tomography, Emission-Computed | 1990 |
Cerebral diaschisis in patients with malignant glioma.
Topics: Brain; Brain Neoplasms; Cerebrovascular Circulation; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans; Tomography, Emission-Computed | 1990 |
Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
Topics: Alzheimer Disease; Brain; Brain Diseases; Brain Neoplasms; Deoxyglucose; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Radiation Injuries; Tomography, Emission-Computed | 1990 |
[Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET].
Topics: Adolescent; Adult; Antineoplastic Agents; Brain; Brain Neoplasms; Carbon Radioisotopes; Cerebrovascular Circulation; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Nimustine; Oxygen Radioisotopes; Tegafur; Tomography, Emission-Computed | 1989 |
Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Tomography, Emission-Computed | 1989 |
[Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning].
Topics: Adenosine Triphosphate; Adult; Blood Glucose; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioma; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphorus; Tomography, Emission-Computed | 1989 |
[Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Edema; Brain Neoplasms; Cerebrovascular Circulation; Child; Child, Preschool; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Hemodynamics; Humans; Male; Meningioma; Middle Aged; Oxygen Consumption; Tomography, Emission-Computed | 1989 |
PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Topics: Astrocytoma; Brachytherapy; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Rubidium Radioisotopes; Tomography, Emission-Computed | 1988 |
Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
Topics: Adult; Aged; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Tomography, Emission-Computed | 1986 |
[In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Cerebrovascular Circulation; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Male; Middle Aged; Oligodendroglioma; Oxygen Consumption; Oxygen Radioisotopes; Tomography, Emission-Computed | 1986 |
Heterogeneity of regional cerebral glucose metabolism demonstrated in situ in rat brain by 19F NMR rotating frame zeugmatography: one dimensional chemical shift imaging of normal and gliosarcoma implanted brain.
Topics: Aldehyde Reductase; Animals; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Magnetic Resonance Spectroscopy; Male; Pentose Phosphate Pathway; Rats; Rats, Inbred Strains; Sorbitol | 1987 |
Positron emission tomography in patients with glioma. A predictor of prognosis.
Topics: Adult; Aged; Brain Neoplasms; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Middle Aged; Pilot Projects; Prognosis; Tomography, Emission-Computed | 1988 |
Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Topics: Adolescent; Adult; Aged; Biological Transport; Brain; Brain Neoplasms; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Phosphorylation; Tomography, Emission-Computed | 1988 |
Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Thiopental; Tomography, Emission-Computed | 1987 |
[Tomographic mapping of rate constants of [F-18] FDG model].
Topics: Brain; Brain Neoplasms; Cerebral Infarction; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Glioma; Humans; Kinetics; Models, Biological; Radioisotopes; Tomography, Emission-Computed | 1985 |
Brain imaging of glucose utilization in cerebral tumors.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1985 |
Regulation of hexokinase in cultured gliomas.
Topics: Cell Line; Cytosol; Deoxyglucose; Fibroblasts; Fluorodeoxyglucose F18; Glioma; Hexokinase; Humans; Isoenzymes; Kinetics; Mitochondria; Tomography, Emission-Computed | 1985 |